IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories, Inc.

Product Revenue

Product Revenue %Chg

Product Revenue Common Size

Service Revenue

Service Revenue %Chg

Service Revenue Common Size

Total Revenue

Total Revenue %Chg

Total Revenue Common Size

Cost of Product Revenue

Cost of Product Revenue %Chg

Cost of Product Revenue Common Size

Cost of Service Revenue

Cost of Service Revenue %Chg

Cost of Service Revenue Common Size

Total Cost of Revenue

Total Cost of Revenue %Chg

Total Cost of Revenue Common Size

Gross Profit

Gross Profit %Chg

Gross Profit Common Size

Sales and Marketing

Sales and Marketing %Chg

Sales and Marketing Common Size

General and Administrative

General and Administrative %Chg

General and Administrative Common Size

Research and Development

Research and Development %Chg

Research and Development Common Size

Impairment Charge

Impairment Charge %Chg

Impairment Charge Common Size

Total Operating Expense

Total Operating Expense %Chg

Total Operating Expense Common Size

Income from Operations

Income from Operations %Chg

Income from Operations Common Size

Interest Expense

Interest Expense %Chg

Interest Expense Common Size

Interest Income

Interest Income %Chg

Interest Income Common Size

Income Before Provision for Income Taxes

Income Before Provision for Income Taxes %Chg

Income Before Provision for Income Taxes Common Size

Provision for Income Taxes

Provision for Income Taxes %Chg

Provision for Income Taxes Common Size

Net Income Attributable to Stockholders

Net Income Attributable to Stockholders %Chg

Net Income Attributable to Stockholders Common Size

Net Income

Net Income %Chg

Net Income Common Size

Less: Net Income Attributable to Noncontrolling Interest

Less: Net Income Attributable to Noncontrolling Interest %Chg

Less: Net Income Attributable to Noncontrolling Interest Common Size

Basic

Basic %Chg

Basic Common Size

Diluted

Diluted %Chg

Diluted Common Size

Total Revenues

Total Revenues %Chg

Total Revenues Common Size

Cost of Sales

Cost of Sales %Chg

Cost of Sales Common Size

Gross Profit Margin

Gross Profit Margin %Chg

Gross Profit Margin Common Size

Selling, General & Administrative Expenses

Selling, General & Administrative Expenses %Chg

Selling, General & Administrative Expenses Common Size

Research & Development Expenses

Research & Development Expenses %Chg

Research & Development Expenses Common Size

Other Operating Expenses

Other Operating Expenses %Chg

Other Operating Expenses Common Size

Operating Profit

Operating Profit %Chg

Operating Profit Common Size

Operating Margin

Operating Margin %Chg

Operating Margin Common Size

Interest and Investment Income

Interest and Investment Income %Chg

Interest and Investment Income Common Size

Total Non-Operating Income

Total Non-Operating Income %Chg

Total Non-Operating Income Common Size

Consolidated Net Income

Consolidated Net Income %Chg

Consolidated Net Income Common Size

Net Income Attributable to Minority Interests and Other

Net Income Attributable to Minority Interests and Other %Chg

Net Income Attributable to Minority Interests and Other Common Size

Net Income Attributable to Common Shareholders

Net Income Attributable to Common Shareholders %Chg

Net Income Attributable to Common Shareholders Common Size

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Adjusted Net Income

Net Revenue

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Income Statement	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24
Total Revenues	4,167.4	4,037.7	3,931.8	3,897.5	3,844.8	3,784.8
Total Revenues %Chg	8.4%	6.7%	5.6%	6.5%	7.2%	7.7%
Product Revenue
Service Revenue
Cost of Sales	1,595.3	1,552.9	1,522.6	1,518.6	1,510.4	1,498.4
Cost of Product Revenue
Cost of Service Revenue
Gross Profit	2,572.1	2,484.8	2,409.2	2,378.9	2,334.4	2,286.4
Gross Profit
Gross Profit Margin	61.7%	61.5%	61.3%	61%	60.7%	60.4%
Selling, General & Administrative Expenses	1,023.9	997	1,037.1	1,030.8	1,008.6	995.2
Sales and Marketing
General and Administrative
Research & Development Expenses	242.1	232.7	226.2	219.8	213.9	207.9
Research and Development
Other Operating Expenses	—	—	—	—	—	—
Impairment Charge
Operating Profit	1,306.1	1,255.2	1,145.9	1,128.3	1,112	1,083.3
Income from Operations
Operating Margin	31.3%	31.1%	29.1%	29%	28.9%	28.6%
Interest and Investment Income	4.6	6.8	9.5	12.7	14.1	12.7
Interest Income
Interest Expense	-37.1	-34.2	-31	-31.2	-33	-33.9
Interest Expense
Total Non-Operating Income	-32.5	-27.4	-21.5	-18.5	-18.8	-21.3
Income Before Provision for Income Taxes	1,273.6	1,227.7	1,124.4	1,109.8	1,093.1	1,062.1
Income Before Provision for Income Taxes
Provision for Income Taxes	246.2	242.1	229.5	222	226.9	216.5
Provision for Income Taxes
Consolidated Net Income	1,027.4	985.7	895	887.9	866.2	845.6
Net Income
Net Income Attributable to Minority Interests and Other	—	—	—	—	—	—
Less: Net Income Attributable to Noncontrolling Interest
Net Income Attributable to Common Shareholders	1,027.4	985.7	895	887.9	866.2	845.6
Net Income Attributable to Stockholders
Basic EPS	12.7	12.1	10.9	10.8	10.5	10.2
Diluted EPS	12.6	12	10.8	10.7	10.4	10.1
Basic Weighted Average Shares Outstanding	80.9	81.5	82	82.5	82.8	83
Total Shares Outstanding	80	108	80.7	80.8	82	82.5
Diluted Weighted Average Shares Outstanding	81.5	82.1	82.7	83.2	83.6	83.8
EBITDA	1,446.3	1,392.8	1,280	1,258.3	1,237.9	1,204.2
Effective Tax Rate	19.3%	19.7%	20.4%	20%	20.8%	20.4%